0001209191-23-024288.txt : 20230414
0001209191-23-024288.hdr.sgml : 20230414
20230414160614
ACCESSION NUMBER: 0001209191-23-024288
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20230412
FILED AS OF DATE: 20230414
DATE AS OF CHANGE: 20230414
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Arkowitz David
CENTRAL INDEX KEY: 0001296999
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37695
FILM NUMBER: 23821171
MAIL ADDRESS:
STREET 1: C/O FLEXION THERAPEUTICS, INC.
STREET 2: 10 MALL ROAD, SUITE 301
CITY: BURLINGTON
STATE: MA
ZIP: 01803
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: KINETA, INC./DE
CENTRAL INDEX KEY: 0001445283
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 219 TERRY AVE. N.
STREET 2: SUITE 300
CITY: SEATTLE
STATE: WA
ZIP: 98109
BUSINESS PHONE: (206) 378-0400
MAIL ADDRESS:
STREET 1: 219 TERRY AVE. N.
STREET 2: SUITE 300
CITY: SEATTLE
STATE: WA
ZIP: 98109
FORMER COMPANY:
FORMER CONFORMED NAME: YUMANITY THERAPEUTICS, INC.
DATE OF NAME CHANGE: 20201223
FORMER COMPANY:
FORMER CONFORMED NAME: PROTEOSTASIS THERAPEUTICS, INC.
DATE OF NAME CHANGE: 20140813
FORMER COMPANY:
FORMER CONFORMED NAME: PROTEOSTASIS THERAPEUTICS INC
DATE OF NAME CHANGE: 20080916
4
1
doc4.xml
FORM 4 SUBMISSION
X0407
4
2023-04-12
0
0001445283
KINETA, INC./DE
KA
0001296999
Arkowitz David
C/O KINETA, INC.
219 TERRY AVE. N., SUITE 300
SEATTLE
WA
98109
1
0
0
0
0
Stock Option (Right to Buy)
3.28
2023-04-12
4
A
0
20000
0.00
A
2033-04-11
Common Stock
20000
20000
D
Stock Option (Right to Buy)
3.28
2023-04-12
4
A
0
12500
0.00
A
2033-04-11
Common Stock
12500
12500
D
The stock option vested and continues to vest as to 1/36 of the total number of shares on February 1, 2023 and on each monthly anniversary thereafter, subject to the continuing service of the Reporting Person on each vesting date.
The stock option will vest as to 1/12 of the total number of shares on July 7, 2023 and each monthly anniversary thereafter, subject to the continuing service of the Reporting Person on each vesting date.
/s/ Pauline Kenny, as Attorney-in-Fact
2023-04-14
EX-24
2
poa.txt
POA DOCUMENT
POWER OF ATTORNEY
The undersigned as a Section 16 reporting person of Kineta, Inc. (the
"Company"), hereby constitutes and appoints Pauline Kenny, Albert W. Vanderlaan
and Nanette Agustines, and each of them, the undersigned's true and lawful
attorney-in-fact to:
(1) execute, deliver and file for and on behalf of the undersigned, in the
undersigned's capacity as an officer and/or director of the Company, Forms 3,
4, and 5 in accordance with Section 16(a) of the Exchange Act;
(2) do and perform any and all acts for and on behalf of the undersigned which
may be necessary or desirable to complete and execute any such Form 3, 4, or 5,
complete and execute any amendment or amendments thereto, and timely file such
form with the SEC and any stock exchange or similar authority;
(3) seek or obtain, as the undersigned's representative and on the undersigned's
behalf, information on transactions in the Company's securities from any third
party, including brokers, employee benefit plan administrators and trustees, and
the undersigned hereby authorizes any such person to release any such
information to the undersigned and approves and ratifies any such release of
information; and
(4) take any other action of any type whatsoever in connection with the
foregoing which, in the opinion of such attorney-in-fact, may be of benefit to,
in the best interest of, or legally required by, the undersigned, it being
understood that the documents executed by such attorney-in-fact on behalf of the
undersigned pursuant to this Power of Attorney shall be in such form and shall
contain such terms and conditions as such attorney-in-fact may approve in such
attorney-in-fact's discretion.
The undersigned hereby grants to each such attorney-in-fact full power
and authority to do and perform any and every act and thing whatsoever
requisite, necessary, or proper to be done in the exercise of any of the rights
and powers herein granted, as fully to all intents and purposes as the
undersigned might or could do if personally present, with full power of
substitution or revocation, hereby ratifying and confirming all that such
attorney-in-fact, or such attorney-in-fact's substitute or substitutes, shall
lawfully do or cause to be done by virtue of this power of attorney and the
rights and powers herein granted. The undersigned acknowledges that the
foregoing attorneys-in-fact, in serving in such capacity at the request of the
undersigned, are not assuming, nor is the Company assuming, any of the
undersigned's responsibilities to comply with Section 16 of the Exchange Act.
The undersigned further acknowledges and agrees that the attorney-in-fact and
the Company are relying on written and oral information provided by the
undersigned to complete such forms and the undersigned is responsible for
reviewing the completed forms prior to their filing. The attorney-in-fact and
the Company are not responsible for any errors or omissions in such filings.
The attorney-in-fact and the Company are not responsible for determining whether
or not the transactions reported could be matched with any other transactions
for the purpose of determining liability for short-swing profits under Section
16(b).
This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Forms 3, 4, and 5 with respect to the
undersigned's holdings of and transactions in securities issued by the Company,
unless earlier revoked by the undersigned in a signed writing delivered to the
Company and the foregoing attorneys-in-fact.
IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to
be executed as of this 16th day of December, 2022.
/s/ David Arkowitz
Name: David Arkowitz